Clinical trial

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

NCT07332455

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-10

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-02-10Date precision: day

Registry last updated2026-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neoplasms, Prostateunresolved

Interventions

GSK5471713DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

MontrealQuebec, Canada2 TokyoJapan2 PhiladelphiaPennsylvania, United States1 TorontoOntario, Canada1 SeoulSouth Korea1 La JollaCalifornia, United States1 MontpellierFrance1 AmsterdamNetherlands1 MelbourneVictoria, Australia1 Grand RapidsMichigan, United States1 NijmegenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07332455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.